Evidence map›Paper›PMID 39049029›Full record

ArticleHarm reduction journal2024

Challenges of the COVID-19 pandemic on women's HIV harm reduction centers: a mixed-methods study.

Azam Rahmani, Maryam Janatolmakan, Elham Rezaei, Leila Allahqoli, Arezoo Fallahi, Elham Ebrahimi, Mahnaz Motamedi, Fatemeh Yousefi, Serap Ejdar Apay

Abstract read
In one paragraph

Article in Harm reduction journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Azam RahmaniNursing and Midwifery Care Research Center, School of Nursing and Midwifery, Tehran University of Medical Sciences, Tehran, Iran.
Maryam JanatolmakanSocial Development and Health Promotion Research Center, Health Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran; Nursing and Midwifery Care Research Center, Tehran University of Medical Sciences, Tehran, Iran. mjanat135@yahoo.com.
Elham RezaeiMidwifery department, School of Nursing and Midwifery, Tabriz University of Medical Sciences, Tabriz, Iran.
Leila AllahqoliMidwifery Department, Ministry of Health and Medical Education, Tehran, Iran.
Arezoo FallahiSocial Determinants of Health Research Center, Research Institute for Health Development, Kurdistan University of Medical Sciences, Sanandaj, Iran.
Elham EbrahimiDepartment of Reproductive Health Midwifery, School of Nursing & Midwifery Nursing and Midwifery Care Research Center, Tehran, Iran.
Mahnaz MotamediHIV/STIs Department, Communicable Disease Control Center, Ministry of Health and Medical Education of Iran, Tehran, Iran.
Fatemeh YousefiDepartment of midwifery, reproductive health promotion research center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Serap Ejdar ApayFaculty of Health Sciences, Atatürk University & Atateknokent Company, Erzurum, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe COVID-19 pandemic has posed significant challenges to nations worldwide, affecting various sectors of society. Women's HIV harm reduction centers, which provide critical services, have also been affected by these difficulties. This study aimed to examine the challenges of the COVID-19 pandemic on the services offered by women's HIV harm reduction centers from the perspective of clients.

methodsA convergent mixed-method design was utilized to gain in-depth insights into the challenges of COVID-19 on the services provided by women's HIV harm reduction centers, counseling centers, and night shelters that cater to women at risk, such as drug users, sex workers, and the homeless population, in three provinces (Tehran, Khuzestan, and Kermanshah) in Iran. The study was conducted from January to May 2023. The quantitative aspect of the study employed a cross-sectional method with a sample size of 430 individuals. A researcher-developed questionnaire was used to assess a range of services. The qualitative part of the study involved traditional content analysis and included 32 individual interviews. The integration of qualitative and quantitative results was performed during the interpretation phase to provide a comprehensive understanding of the challenges of COVID-19 on women's HIV harm reduction centers.

resultsIn the quantitative phase, the mean age of women was 39.0 ± 10.2 years. 165 women reported a history of COVID-19, which accounts for 38.4% of the total. More than half of them (n = 102, 61.8%) recovering at home. The majority of women (n = 365, 84.9%) mentioned receiving the COVID-19 vaccine. COVID-19 diagnostic tests were conducted for 74.2% (n = 319) of women. Women expressed higher satisfaction with the services (HIV prevention services, and accommodation services) before the COVID-19 pandemic compared to the satisfaction during the pandemic. The qualitative analysis identified emerging challenges related to the COVID-19 pandemic in two categories: personal challenges and mismanagement of services, comprising nineteen subcategories.

conclusionThe findings of this study highlight the adverse impact of the COVID-19 pandemic on the services provided by women's HIV harm reduction centers, in contrast to the pre-pandemic period. To mitigate these negative effects, it is crucial to implement preventive measures and practical solutions. This may involve addressing the personal and management challenges of the centers.

Indexed as

COVID-19Harm ReductionHIV InfectionsAdultCross-Sectional StudiesFemaleHumansIll-Housed PersonsIranMiddle AgedPandemicsSex WorkersSurveys and QuestionnairesYoung AdultCOVID-19Drop in centerHigh risk womenHIV, Harm reductionMixed method

Identifiers

PMID39049029
PMCPMC11267809

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.